Affiliation:
1. Lady Davis Institute for Medical Research Jewish General Hospital Montreal QC Canada
2. Department of Biochemistry McGill University Montreal QC Canada
3. Department of Oncology McGill University Montreal QC Canada
Abstract
AbstractDeadenylation‐dependent mRNA decapping and decay is the major cytoplasmic mRNA turnover pathway in eukaryotes. Many mRNA decapping and decay factors are associated with each other via protein–protein interaction motifs. For example, the decapping enzyme DCP2 and the 5'–3' exonuclease XRN1 interact with the enhancer of mRNA‐decapping protein 4 (EDC4), a large scaffold that has been reported to stimulate mRNA decapping. mRNA decapping and decay factors are also found in processing bodies (P‐bodies), evolutionarily conserved ribonucleoprotein granules that are often enriched with mRNAs targeted for decay, yet paradoxically are not required for mRNA decay to occur. Here, we show that disrupting the EDC4‐XRN1 interaction or altering their stoichiometry inhibits mRNA decapping, with microRNA‐targeted mRNAs being stabilized in a translationally repressed state. Importantly, we demonstrate that this concomitantly leads to larger P‐bodies that are responsible for preventing mRNA decapping. Finally, we demonstrate that P‐bodies support cell viability and prevent stress granule formation when XRN1 is limiting. Taken together, these data demonstrate that the interaction between XRN1 and EDC4 regulates P‐body dynamics to properly coordinate mRNA decapping with 5′–3′ decay in human cells.
Funder
Natural Sciences and Engineering Research Council of Canada
Publisher
Springer Science and Business Media LLC
Subject
General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Molecular Biology,General Neuroscience
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献